Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...

Künftig soll rund ein Drittel der neuen Produkte bei Boehringer Ingelheim aus der Onkologie kommen. Im Zentrum der Entwicklungen stehen zum Beispiel neue Therapiezugänge, bei denen einerseits ...

Boehringer Ingelheim gibt heute bekannt, dass der Gesellschafterausschuss die folgenden Änderungen in der Unternehmensleitung vorgenommen hat: Carinne Brouillon, Mitglied der Unternehmensleitung ...

Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...

By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.

Boehringer Ingelheim and Takeda are the only two pharmaceutical groups to be named among the 15 Global Top Employers for 2023, an award dedicated to companies that enrich the workplace environment.

Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...

She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well, Dr. Hinsch Gylvin. Thanks for joining me today. That really has changed. So first and foremost ...

Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.